Targeted Drug Combination Induces Remission in CLL Patients, Improving Survival and Quality of Life
A phase III clinical trial, FLAIR, demonstrated that a combination of venetoclax and ibrutinib is more effective than chemotherapy for chronic lymphocytic leukemia (CLL).
© Copyright 2025. All Rights Reserved by MedPath